Skip to main content
Response to Comments on “Aberrant type 1 immunity drives susceptibility to mucosal fungal infections”
- Break, Timothy J;
- Oikonomou, Vasileios;
- Dutzan, Nicolas;
- Desai, Jigar V;
- Swidergall, Marc;
- Freiwald, Tilo;
- Chauss, Daniel;
- Harrison, Oliver J;
- Alejo, Julie;
- Williams, Drake W;
- Pittaluga, Stefania;
- Lee, Chyi-Chia R;
- Bouladoux, Nicolas;
- Swamydas, Muthulekha;
- Hoffman, Kevin W;
- Greenwell-Wild, Teresa;
- Bruno, Vincent M;
- Rosen, Lindsey B;
- Lwin, Wint;
- Renteria, Andy;
- Pontejo, Sergio M;
- Shannon, John P;
- Myles, Ian A;
- Olbrich, Peter;
- Ferré, Elise MN;
- Schmitt, Monica;
- Martin, Daniel;
- Core16, Genomics and Computational Biology;
- Barber, Daniel L;
- Solis, Norma V;
- Notarangelo, Luigi D;
- Serreze, David V;
- Matsumoto, Mitsuru;
- Hickman, Heather D;
- Murphy, Philip M;
- Anderson, Mark S;
- Lim, Jean K;
- Holland, Steven M;
- Filler, Scott G;
- Afzali, Behdad;
- Belkaid, Yasmine;
- Moutsopoulos, Niki M;
- Lionakis, Michail S
- et al.
Published Web Location
https://www.science.org/doi/10.1126/science.abi8835?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmedNo data is associated with this publication.
Abstract
Puel and Casanova and Kisand et al. challenge our conclusions that interferonopathy and not IL-17/IL-22 autoantibodies promote candidiasis in autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy. We acknowledge that conclusive evidence for causation is difficult to obtain in complex human diseases. However, our studies clearly document interferonopathy driving mucosal candidiasis with intact IL-17/IL-22 responses in Aire-deficient mice, with strong corroborative evidence in patients.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.